Susan Hardy - Charles River Corporate Vice President Investor Relations

CRL Stock  USD 239.43  0.70  0.29%   

President

Susan Hardy is Corporate Vice President Investor Relations of Charles River Laboratories since 2017.
Tenure 7 years
Address 251 Ballardvale Street, Wilmington, MA, United States, 01887
Phone781 222 6000
Webhttps://www.criver.com

Charles River Management Efficiency

The company has Return on Asset of 0.0519 % which means that on every $100 spent on assets, it made $0.0519 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1438 %, implying that it generated $0.1438 on every 100 dollars invested. Charles River's management efficiency ratios could be used to measure how well Charles River manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Charles River's Return On Capital Employed is quite stable compared to the past year. Return On Assets is expected to rise to 0.06 this year, although the value of Return On Tangible Assets will most likely fall to 0.12. At this time, Charles River's Return On Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.67 this year, although the value of Intangible Assets will most likely fall to about 480.2 M.
The company has 3.07 B in debt with debt to equity (D/E) ratio of 1.27, which is OK given its current industry classification. Charles River Labora has a current ratio of 1.3, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist Charles River until it has trouble settling it off, either with new capital or with free cash flow. So, Charles River's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Charles River Labora sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Charles to invest in growth at high rates of return. When we think about Charles River's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Jacqueline StuderIDEXX Laboratories
58
Ian KingWaters
63
Scott FrommerLaboratory of
N/A
Melissa HerbertNeogen
53
Jerome HagedornNeogen
51
Rohit KhannaWaters
58
Joseph CorbettNeogen
48
Kenneth KodillaNeogen
59
Kathy TurnerIDEXX Laboratories
54
Glenn EisenbergLaboratory of
63
Pat VentersIDEXX Laboratories
N/A
Mark BrecherLaboratory of
57
Jason LillyNeogen
43
Robert DonofrioNeogen
49
Mark BeaudouinWaters
63
John LynchWaters
N/A
Mark DanielsTwist Bioscience Corp
55
Sandra VaartLaboratory of
64
Martin KunzTwist Bioscience Corp
47
Robert CarsonWaters
46
Shane FitzwaterNeogen
43
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts. Charles River operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18600 people. Charles River Laboratories (CRL) is traded on New York Stock Exchange in USA. It is located in 251 Ballardvale Street, Wilmington, MA, United States, 01887 and employs 20,400 people. Charles River is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Charles River Labora Leadership Team

Elected by the shareholders, the Charles River's board of directors comprises two types of representatives: Charles River inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Charles. The board's role is to monitor Charles River's management team and ensure that shareholders' interests are well served. Charles River's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Charles River's outside directors are responsible for providing unbiased perspectives on the board's policies.
Craig Thompson, Director
Robert Bertolini, Independent Director
Birgit Girshick, Corporate Executive Vice President, Global Discovery and Safety Assessment, Biologics and Avian
James Foster, Chairman of the Board, President, Chief Executive Officer
Joseph LaPlume, Corporate Executive Vice President - Corporate Development and Strategy
Mark Mintz, Corporate Officer
Michael Knell, Corporate Senior Vice President Chief Accounting Officer
George Milne, Lead Independent Director
Thomas Ackerman, CFO and Corporate Executive VP
George Llado, Independent Director
Nancy Andrews, Independent Director
Victoria Creamer, Corporate Senior Vice President Chief People Officer.
JeanPaul Mangeolle, Independent Director
Gina Mullane, Chief VP
Richard Wallman, Independent Director
Pr Frearson, Corporate Officer
David Smith, Chief Financial Officer, Corporate Executive Vice President
James JD, CEO Chairman
Matthew Daniel, General VP
Nancy Gillett, Chief Scientific Officer, Corporate Executive Vice President
Martin Mackay, Independent Director
Virginia Wilson, Independent Director
Flavia Pease, Corporate Executive Vice President
Emily Hickey, Corporate Senior Vice President - Global Discovery Services
Amy Cianciaruso, Corporate Officer
Todd Spencer, Corporate Relations
David Johst, Corporate Executive Vice President - Human Resources, Chief Administrative Officer, General Counsel
Deborah Kochevar, Independent Director
William Barbo, Corporate Executive Vice President and Chief Commercial Officer
Stephen Chubb, Independent Director
Richard Reese, Independent Director
Davide Molho, Corporate Executive Vice President ; President Global Research Models & Services and Preclinical Services Operations
George Massaro, Independent Director
Susan Hardy, Corporate Vice President Investor Relations

Charles Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Charles River a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Charles River

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Charles River position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charles River will appreciate offsetting losses from the drop in the long position's value.

Moving against Charles Stock

  0.74BNR Burning Rock BiotechLtd Financial Report 4th of June 2024 PairCorr
  0.69KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.58VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Charles River could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Charles River when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Charles River - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Charles River Laboratories to buy it.
The correlation of Charles River is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Charles River moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Charles River Labora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Charles River can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Charles Stock analysis

When running Charles River's price analysis, check to measure Charles River's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Charles River is operating at the current time. Most of Charles River's value examination focuses on studying past and present price action to predict the probability of Charles River's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Charles River's price. Additionally, you may evaluate how the addition of Charles River to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
CEOs Directory
Screen CEOs from public companies around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Charles River's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.01)
Earnings Share
9.22
Revenue Per Share
80.61
Quarterly Revenue Growth
(0.08)
Return On Assets
0.0519
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.